Jim Cramer on Allergan: There Are So Many Sellers Off the Goldman Downgrade
TheStreet's Jim Cramer said Goldman Sachs' downgrade of Allergan was not "thoughtful" in terms of the company's fundamentals.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Goldman Sachs' downgrade of Allergan (AGN) - Get Report was not "thoughtful" in terms of the company's fundamentals.
Trending right now on TheStreet:
- ESPN Woes Overshadow Disney's Strong Showing in Parks and Movies: What Wall Street's Saying
- In an Extremely Rare Interview, Sears CEO Eddie Lampert Proves He's Pretty Much Lost
- Bull Market Reaching Mature Stage, Dow Could Dip to 19,000
- Jim Cramer Discusses Disney, Yelp, Nvidia, Allergan, Abercrombie, Macy's and Kohl's
- Walmart's Jet.com Finally Has a Physical Store Open--What It Sells Will Surprise You
- Snap's Much-Anticipated First Earnings Report as A Public Company -- Here's What to Watch
Jim Cramer and Real Money columnists discuss the latest from President Donald Trump and the GOP efforts to repeal and replace the Affordable Care Act. See which stocks they are discussing and get his insights or analysis with a free trial subscription to Real Money.
